◆英語タイトル:A1M Pharma AB (A1M) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010867
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月20日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
A1M Pharma AB (A1M Pharma) develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. The company offers ROSgard based on A1M (alpha-1-microglobulin), an endogenous protein with properties that captures and eliminates toxic substances from the cells metabolism. Its A1M helps to prevent and ameliorate some of the damage caused by oxidative stress and inflammation. A1M Pharma develops novel diagnostic test for preeclampsia based on the biomarker fetal hemoglobin. The company also develops treatments for kidney damage. It provides constitute therapeutic or diagnostic tools for various conditions and illnesses in animals and humans. A1M Pharma is headquartered in Lund, Sweden.
A1M Pharma AB (A1M) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
A1M Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
A1M Pharma AB, Medical Devices Deals, 2011 to YTD 2017 9
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
A1M Pharma AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
A1M Pharma Partnered with Clinical Trial Consultants 11
A1M Pharma Enters into Agreement with Research Toxicology Centre 12
A1M Pharma Enters into Research Agreement with CSL Behring 13
A1M Pharma Enters into Rresearch Agreement with Fred Hutchinson Cancer Research Centre 14
A1M Pharma Expands Agreement with European Pharmaceutical Company 15
A1M Pharma Enters into Partnership with Truly Translational 16
NeuroVive Pharmal And A1M Pharma Enter Into Research Agreement 17
Equity Offering 18
A1M Pharma Plans to Raise USD13.82 Million in Public Offering of Shares 18
A1M Pharma Raises USD5 Million in Rights Offering of Shares 19
A1M Pharma Raises USD3.7 Million in Rights Offering of Shares 20
A1M Pharma Raises USD3.61 Million in Rights Offering of Shares 21
A1M Pharma AB – Key Competitors 22
A1M Pharma AB – Key Employees 23
A1M Pharma AB – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Product News 25
09/13/2016: A1M Pharma selects kidney protection in connection with cancer treatment as their first indication within acute kidney injury 25
02/10/2017: A1M Pharma has successfully conducted large scale manufacturing of the active substance in ROSGard and initiates GLP toxicology studies 26
Product Approvals 27
Sep 09, 2016: A1M Pharma applies for trademark protection for ROSGard as the name of the companys candidate drug RMC-035 27
Clinical Trials 28
Jun 12, 2017: A1M Pharma announces progress in the preclinical development of ROSGard 28
Mar 29, 2017: A1M Pharma: ROSGard shows strong protective effect against renal damage in connection with radiation therapy in a preclinical long-term study 29
Dec 09, 2016: ROSGard shows renal protective effect during radiation therapy 30
Nov 29, 2016: A1M Pharma has successfully conducted preclinical toxicology/safety studies within preeclampsia 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
A1M Pharma AB, Pharmaceuticals & Healthcare, Key Facts 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
A1M Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
A1M Pharma AB, Deals By Therapy Area, 2011 to YTD 2017 8
A1M Pharma AB, Medical Devices Deals, 2011 to YTD 2017 9
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
A1M Pharma Partnered with Clinical Trial Consultants 11
A1M Pharma Enters into Agreement with Research Toxicology Centre 12
A1M Pharma Enters into Research Agreement with CSL Behring 13
A1M Pharma Enters into Rresearch Agreement with Fred Hutchinson Cancer Research Centre 14
A1M Pharma Expands Agreement with European Pharmaceutical Company 15
A1M Pharma Enters into Partnership with Truly Translational 16
NeuroVive Pharmal And A1M Pharma Enter Into Research Agreement 17
A1M Pharma Plans to Raise USD13.82 Million in Public Offering of Shares 18
A1M Pharma Raises USD5 Million in Rights Offering of Shares 19
A1M Pharma Raises USD3.7 Million in Rights Offering of Shares 20
A1M Pharma Raises USD3.61 Million in Rights Offering of Shares 21
A1M Pharma AB, Key Competitors 22
A1M Pharma AB, Key Employees 23
A1M Pharma AB, Subsidiaries 24